BioMarin to Participate in Four Upcoming Virtual Investor Conferences

- J.P. Morgan U.S. All Stars Conference on September 16 at 11:00am ET/4:00BST

SAN RAFAEL, Calif., Sept. 15, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in four upcoming virtual conferences.  An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates. 

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:  


Investors                                                  

Media

Traci McCarty                                             

Debra Charlesworth

BioMarin Pharmaceutical Inc.                         

BioMarin Pharmaceutical Inc.

(415) 455-7558                                                

(415) 455-7451

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-four-upcoming-virtual-investor-conferences-301128234.html

SOURCE BioMarin Pharmaceutical Inc.